Cartesian Therapeutics, Inc. RNAC

7.41 (0.21) (2.76%) as of 25 Sep
Market cap
$230.6M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
125.14 212.61 76.91 134.60 128.06 138.69 90.17 37.40 96.64 84.22
Receivables
1.12 0.87 8.85 9.76 9.91 7.22 5.00 — 0.06 0.22
Total current assets
129.28 216.63 90.73 148.14 144.44 151.34 96.67 42.08 98.68 86.82
Property, Plant, Equpment (Net)
12.19 9.91 2.11 2.79 2.14 1.40 1.22 2.13 2.09 2.05
Long-Term Investments
— 2.00 2.00 2.00 2.00 1.38 1.38 0.28 — —
Goodwill and Intangible Assets (Total)
48.16 48.16 48.16 — — — — — — —
Long-term assets (Other)
101.19 152.79 151.98 1.34 1.47 1.75 1.38 0.28 0.33 0.44
Total non-current assets
167.14 218.40 214.32 17.75 15.44 14.09 2.90 2.41 2.42 2.49
Total Assets
296.41 435.02 305.05 165.89 159.88 165.44 99.57 44.48 101.10 89.30
Accounts Payable
1.29 0.29 3.15 0.32 0.22 0.44 0.50 1.10 1.61 3.88
Accrued Expenses
9.50 12.08 15.57 14.08 10.53 8.15 13.49 11.70 8.58 3.92
Current Part of Debt
— — — 8.48 5.96 0.91 18.91 21.39 — 4.07
Current Part of Taxes to Pay
— — — 0.00 0.60 0.00 — — — —
Current Revenue (Deferred)
— 0.00 2.31 0.59 53.88 72.05 1.67 0.96 0.79 1.84
Other current liabilities
— 7.76 45.01 14.68 64.42 80.20 15.17 12.66 9.37 5.76
Total current liabilities
14.94 22.98 68.21 25.08 72.25 81.55 34.94 35.14 10.97 13.71
Long Term Debt (Total)
— — — 17.79 19.67 24.79 — — 21.04 7.98
Non-current Revenue (Deferred)
— — 3.54 0.00 11.42 38.75 14.68 13.82 16.07 12.66
Long Term Tax Liability (Deferred)
6.95 16.14 15.85 — — — — — — —
Non-current Liabilities (Other)
392.24 391.58 348.29 19.14 25.42 28.71 41.55 0.94 1.20 0.22
Total non-current liabilities
407.71 418.85 376.47 46.98 65.11 101.89 56.23 14.76 38.31 20.64
Total liabilities
422.65 441.83 444.68 72.06 137.36 183.44 91.17 49.90 49.29 34.34
Additional Paid In Capital
700.71 689.89 179.06 493.31 457.39 391.18 348.66 279.54 273.13 211.13
Preferred Stock (Total)
— — 300.55 — — — — — — —
Common Stock (Net)
0.00 0.00 0.00 0.02 0.01 0.01 0.01 0.00 0.00 0.00
Retained Earnings
(822.37) (692.07) (614.65) (394.94) (430.32) (404.63) (335.75) (280.40) (216.90) (151.58)
Shareholders Equity (Other)
— — — — — — — — — (0.07)
Common Equity (Total)
(126.24) (6.80) (440.18) 93.83 22.52 (18.01) 8.40 (5.42) 51.81 54.96
Shareholders Equity (Total)
(126.24) (6.80) (139.63) 93.83 22.52 (18.01) 8.40 (5.42) 51.81 54.96
Shareholders Equity and Liabilities (Total)
296.41 435.02 305.05 165.89 159.88 165.44 99.57 44.48 101.10 89.30
Shares (Common)
26.01 25.77 5.40 5.10 4.12 3.60 2.87 0.75 0.74 0.61
Shares (Preferred)
121.23 121.23 435.12 — — — — — — —
Shareholders Equity (Tangible)
(174.40) (54.96) (187.79) 93.83 22.52 (18.01) 8.40 (5.42) 51.81 54.96
Net Debt
(125.14) (212.61) (76.91) (108.34) (102.42) (112.98) (71.27) (16.02) (75.60) (72.17)
Total Debt
— — — 26.26 25.63 25.70 18.91 21.39 21.04 12.04

Fold the line items

In millions of $ except per-share values · columns are period end dates